Icahn nominates 3 for Biogen board

Cambridge biotechnology company Biogen Idec Inc. today announced that it has received notice from Icahn Partners LP and certain of its affiliates for the nomination of three individuals to the company's board at its 2008 annual meeting.

The individuals are Alexander J. Denner, Richard C. Mulligan, and Anne B. Young, the company said.

Biogen Idec said that its board "will review the notice and consider it in light of the best interests of all shareholders of the company."

According to Globe stories, billionaire investor Carl Icahn helped push Biogen Idec to put itself up for sale in October. As of September, Icahn owned about 4 percent of the company's shares.

Biogen Idec later called off its search for a buyer, saying it didn't receive a single offer, but Icahn has said he still believes the company could be sold, the Globe later reported.
(By Chris Reidy, Globe staff)